Oncology & Cancer
Study highlights possible new approach to prostate cancer treatment
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer.
Aug 1, 2013
0
0
News tagged with prostate cancer progression
Oncology & Cancer
Use of ADT for treatment of prostate cancer linked with increased risk of kidney injury
In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy (ADT) was associated with a significantly increased risk of acute kidney injury, with variations observed ...
Jul 16, 2013
0
0
Oncology & Cancer
New study on popular prostate cancer protein provides insight into disease progression
Researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute have uncovered for the first time the vital role a popular protein plays in the stroma, the cell-lined area outside of a prostate tumor.
Jun 25, 2013
0
0
Oncology & Cancer
Men with prostate cancer should eat healthy vegetable fats
Men with prostate cancer may significantly improve their survival chances with a simple change in their diet, a new study led by UC San Francisco has found.
Jun 10, 2013
0
1
Oncology & Cancer
A rise in early diagnosis of prostate cancer
(Medical Xpress)—Over the last two decades, incremental gains have been made in the number of men given early diagnosis of prostate cancer, and the way they are treated, a Victorian study found.
Jun 3, 2013
0
0
Oncology & Cancer
Mayo Clinic genomic analysis lends insight to prostate cancer
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
May 23, 2013
0
0
Oncology & Cancer
Newly identified tumor suppressor provides therapeutic target for prostate cancer
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified how an enzyme called PKCζ suppresses prostate tumor formation. The finding, which also describes a molecular chain of events that ...
Apr 1, 2013
0
0
Oncology & Cancer
York scientists discover driving force behind prostate cancer
Scientists at the University of York have discovered the driving force behind the development of prostate cancer.
Mar 27, 2013
0
1
Oncology & Cancer
Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.
Mar 15, 2013
0
0
Oncology & Cancer
Focal therapy offers middle ground for some prostate cancer patients
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. ...
Mar 5, 2013
0
0
